Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5645631 | 0.96 | NR3C1 (0.48) | NR3C1PGR | |
| SCHEMBL6585630 | 0.86 | NR3C1 (0.51) | NR3C1PGR | |
| SCHEMBL6584187 | 0.85 | NR3C1 (0.52) | NR3C1PGR | |
| SCHEMBL6585728 | 0.83 | NR3C1 (0.51) | NR3C1PGR | |
| SCHEMBL5642602 | 0.82 | NR3C1 (0.45) | NR3C1PGR | |
| SCHEMBL5642710 | 0.81 | NR3C1 (0.69) | NR3C1 | |
| SCHEMBL7170059 | 0.81 | NR3C1 (0.69) | NR3C1 | |
| SCHEMBL5642293 | 0.80 | NR3C1 (0.69) | NR3C1 | |
| SCHEMBL5077893 | 0.79 | NR3C1 (0.48) | NR3C1PGR | |
| SCHEMBL14604853 | 0.79 | NR3C1 (0.52) | NR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1440976-B1 | Modified aminoacids, pharmaceuticals containing these compounds and method for their production | BOEHRINGER INGELHEIM PHARMA (DE) | 2008-07-23 | — | — | EP | claimed |
| EP-1529051-B1 | GROUP 4 METAL COMPLEXES CONTAINING 4-ARYL-SUBSTITUTED, TRICYCLIC INDENYL DERIVATIVES | DOW GLOBAL TECHNOLOGIES INC (US) | 2008-07-02 | — | — | EP | claimed |
| EP-1017701-B1 | CYCLOPENTAPHENANTHRENYL TITANIUM COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC (US) | 2003-03-19 | — | — | EP | claimed |
| EP-0874860-B1 | SUBSTITUTED INDENYL CONTAINING METAL COMPLEXES AND OLEFIN POLYMERIZATION PROCESS | DOW CHEMICAL CO (US) | 2002-11-13 | — | — | EP | claimed |
| EP-0946575-B1 | FUSED RING SUBSTITUTED INDENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW CHEMICAL CO (US) | 2001-10-10 | — | — | EP | claimed |
| EP-0019369-B1 | ISOTHIOUREIDO ISOINDOLEDIONES, PROCESS FOR THEIR PREPARATION AND USE AS PLANT REGULATORS | Gulf Oil Corporation (US) | 1984-03-07 | — | — | EP | claimed |
| EP-2904034-B1 | METHOD FOR PREPARING A STATISTICAL COPOLYMER BASED ON DIENE MONOMERS AND CYCLIC CARBOSILANE MONOMERS | MICHELIN & CIE (FR) | 2018-04-18 | — | — | EP | disclosed |
| EP-1902049-A2 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-03-26 | — | — | EP | disclosed |
| US-20070010514-A1 | Non-steroidal progesterone receptor modulators | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-01-11 | — | — | US | disclosed |
| WO-2006136461-A2 | NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010514-A1 | Non-steroidal progesterone receptor modulators | PGR, PGRMC1, CYP19A1 | NR3C1 69/4885PGR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.